NeuBase Therapeutics, Inc.

  • ABOUT US
  • TECHNOLOGY
  • PIPELINE
  • PATIENTS
  • PARTNERING
  • INVESTORS
  • CONTACT US

In The News

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar
  • Email Alerts
July 16, 2019

Dietrich Stephan On The New Nasdaq Stock NBSE

July 10, 2019

Pittsburgh's newest public company could debut next week

June 10, 2019

Platform plays offer opportunity, potential pitfalls

March 22, 2019

Interview with the CEO: NeuBase Therapeutics, Inc. (NASDAQ:NBSE)

March 22, 2019

Targeting Repeat Expansion Disorders with Next-Gen Antisense Drugs

March 11, 2019

NeuBase Therapeutics announces $9M financing agreement

January 11, 2019

JPM19: How Little Fish in the Big Ocean Get Noticed Without Being Eaten by Sharks

January 10, 2019

For tiny biotechs, J.P. Morgan is a big opportunity — and a big cost

January 5, 2019

Biotech kicks off the year with conferences in San Francisco

January 4, 2019

LifeX's NeuBase Therapeutics is acquired by Ohr Pharmaceutical

rss_feed RSS
  • arrow_back
  • 1
  • 2
  • 3
  • arrow_forward
  • Email Alerts
  • Contacts
  • RSS News Feed
Neubase

NeuBase Therapeutics, Inc.
350 Technology Drive
Pittsburgh, PA 15219

info@neubasetherapeutics.com

Sign up for news

©2022 NeuBase Therapeutics, Inc. All rights reserved.

Privacy Policy|Terms of Use